in vitro study with the nasogastric tube, CI [Regulatives / Guidelines]

posted by Nataliia – Ukraine, 2021-02-16 14:08 (1550 d 07:27 ago) – Posting: # 22211
Views: 2,962

Dear colleagues, does anyone have the experience in conducting in vitro study with the nasogastric tube?

According to FDA Draft Guidance: «The T/R recovery ratio and the 90% confidence interval of the T/R recovery ratio should be calculated», but bioequivalence CI limits were not specified.

Would you kindly write CI limits for in vitro study with the nasogastric tube?
Is it 80,00-125,00?

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,671 registered users;
131 visitors (0 registered, 131 guests [including 11 identified bots]).
Forum time: 22:35 CEST (Europe/Vienna)

A statistical analysis, properly conducted, is a delicate dissection of
uncertainties, a surgery of suppositions.    Micheal J. Moroney

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5